All News

Donald Klepser, PhD, MBA, professor and dean of academic affairs at the College of Pharmacy in the University of Nebraska Medical Center, discusses how pharmacy technicians can manage their own stress and burnout.

This inflammation of the colon poses a substantial burden to patients and the health care system.

Lumryz (FT218) treats cataplexy and excessive daytime sleepiness caused by narcolepsy.

Pharmacy’s workers' compensation claims for medication expenses are basis of action.

Quality refers to a set of systems that minimizes errors, maximizes performance and efficiency, and which provides the user with an optimal experience to receive the greatest health benefits.

Hyqvia is an immune globulin with a recombinant human hyaluronidase indicated for the treatment of primary immunodeficiency in adults.

Physician’s Choice Joint Support helps with joint flexibility and repair, as well as a healthy inflammatory response.

Indications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.

Pharmacies are so much more attuned to being able to use that technician to the top of his or her license and credential.

Patients at highest risk of cancer recurrence, including people with lymph node-positive disease, saw the greatest reduction in the risk of recurrence or death with the pertuzumab-based regimen

Zonisade is the first and only FDA-approved oral liquid formulation of zonisamide, which helps patients with epilepsy who have difficulty swallowing tablets.

We spend a lot of time harping on vaccine hesitancy, but one thing we don't talk about is vaccine access, and that is really a very key indicator to a lack of cultural competency.

Mark these products for mandatory patient education on the cartons and in the pharmacy computer system.

Organizations such as the Appalachian Community Cancer Alliance are working to leverage technology and improve barriers to care.

Pharmacists are in an excellent position to educate and counsel patients on current recommendations.

Logan Franck, PharmD, BCACP, a clinical associate professor in the College of Pharmacy at the University of Nebraska Medical Center, discuses his American Association of Pharmacy Technicians session on over-the-counter medications.

Treatment's approval marks exciting new development for patients with ES-SCLC to prevent CIM.

Results are first to show causal relationship between losing mLOY in the blood and development of cardiovascular disease.

Data indicate that consumption of 7 or more units of alcohol per week is associated with higher iron levels in the brain, which has been linked to Alzheimer and Parkinson diseases.

Ruxolitinib (Opzelura; Incyte) cream 1.5% is the first and only treatment approved by the FDA for repigmentation in patients with vitiligo.

This month, we spoke with Bob Luschen, PharmD, clinical coordinator for the pharmacy department at cancer Treatment Centers of America, Atlanta.

Dalbavancin (Dalvance) is indicated for acute bacterial skin and skin structure infections caused by designated susceptible strains of Gram-positive microorganisms.

MoveMD is intended for joint pain and discomfort.

It's really important that we capitalize on this time and the impact that pharmacists had to make some of this reform permanent.

Tildrakizumab-asmn is a humanized IgG1/k monoclonal anti-IL-23 antibody indicated for the treatment of adults with moderate-to-severe plaque psoriasis.

Health system specialty pharmacies help remove barriers to care, optimize therapy, and improve outcomes.

Use of these drugs as medications, though, promising, may be restricted for various reasons to a select few.

Pharmacists can leverage patient medical history for formulating effective drugs, and patients can also benefit from single dosage, greater efficacy, and affordability of compounded medications.

Data from Roche’s phase 3 HAVEN 6 study show clinically meaningful bleed control, with no new safety signals observed.

Phase 3 study follows recent approval of the drug for the same condition in individuals aged 12 years and older who weight at least 40 kg.